Chennai Meenakshi Multispeciality Intrinsic Value
Chennai Meenakshi Multispeciality (CMMHOSP) median intrinsic value is ₹23.21 from 3 valuation models (range ₹15–₹38), vs current price ₹38.69 — -40.0% downside (Trading Above Calculated Value), margin of safety -66.7%. Also explore CMMHOSP stock price history to track price trends across different timeframes.
CMMHOSP Valuation Methods Summary — DCF, Graham Number & P/E
Chennai Meenakshi Multispeciality intrinsic value across 3 models vs current price ₹38.69 — upside/downside and value range per method. Browse CMMHOSP financial statements for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Revenue Multiple Method | revenue | ₹38.00 | ₹34.20 - ₹41.80 | -1.8% | Revenue/Share: ₹47.50, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹15.48 | ₹13.93 - ₹17.03 | -60.0% | EBITDA: ₹1.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹23.21 | ₹18.57 - ₹27.85 | -40.0% | CF Growth: 5.0%, Discount: 15% |
CMMHOSP Intrinsic Value vs Market Price — All Valuation Models
Chennai Meenakshi Multispeciality fair value range ₹15–₹38 vs current market price ₹38.69 across 3 valuation models. For current market price and key ratios, visit CMMHOSP share price screener.
CMMHOSP Intrinsic Value Analysis — Undervalued or Overvalued?
Chennai Meenakshi Multispeciality median intrinsic value ₹23.21, current price ₹38.69 — Trading Above Calculated Value by 40.0%, margin of safety -66.7%.
What is the intrinsic value of CMMHOSP?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Chennai Meenakshi Multispeciality (CMMHOSP) is ₹23.21 (median value). With the current market price of ₹38.69, this represents a -40.0% variance from our estimated fair value.
The valuation range spans from ₹15.48 to ₹38.00, indicating ₹15.48 - ₹38.00.
Is CMMHOSP undervalued or overvalued?
Based on our multi-method analysis, Chennai Meenakshi Multispeciality (CMMHOSP) appears to be trading above calculated value by approximately 40.0%.
CMMHOSP Financial Health — Key Ratios vs Industry Benchmarks
Chennai Meenakshi Multispeciality financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.58 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 50.0% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | -1.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.65x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
CMMHOSP Cash Flow Quality — Operating & Free Cash Flow
Chennai Meenakshi Multispeciality operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹2 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹2 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹3 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹4 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹3 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |